NYSE : PEN
Penumbra, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 321.97 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 12.68B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 12.57B |
| Enterprise Value | 12.11B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 39.41M |
| Shares Outstanding | 39.41M |
| Shares Change (YoY) | -0.31% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 2.75% |
| Owned by Institutions (%) | 88.07% |
| Float | 38.30M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 80.37 |
| Forward PE | 53.63 |
| PS Ratio | 8.06 |
| Forward PS | 7.14 |
| PB Ratio | 7.94 |
| P/TBV Ratio | 8.91 |
| P/FCF Ratio | 62.76 |
| P/OCF Ratio | 48.16 |
| PEG Ratio | 1.54 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 77.11 |
| EV / Sales | 7.76 |
| EV / EBITDA | 57.88 |
| EV / EBIT | 63.98 |
| EV / FCF | 60.45 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 5.89 |
| Quick Ratio | 3.72 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 0.85 |
| Debt / FCF | 1.05 |
| Interest Coverage | 149.60 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 10.67% |
| Return on Assets (ROA) | 6.28% |
| Return on Invested Capital (ROIC) | 12.98% |
| Return on Capital Employed (ROCE) | 10.56% |
| Weighted Average Cost of Capital (WACC) | 7.92% |
| Revenue Per Employee | $331,986 |
| Profits Per Employee | $33,408 |
| Employee Count | 4,700 |
| Asset Turnover | 0.83 |
| Inventory Turnover | 1.12 |
Taxes
| Measure | Value |
|---|
| Income Tax | 50.81M |
| Effective Tax Rate | 24.45% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.69 |
| 52-Week Price Change | +36.67% |
| 50-Day Moving Average | 320.50 |
| 200-Day Moving Average | 327.49 |
| Relative Strength Index (RSI) | 44.73 |
| Average Volume (20 Days) | 403,849 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 2.26M |
| Short Previous Month | 1.81M |
| Short % of Shares Out | 5.74% |
| Short % of Float | 5.91% |
| Short Ratio (days to cover) | 5.55 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1.56B |
| Gross Profit | 1.06B |
| Operating Income | 189.25M |
| Pretax Income | 207.82M |
| Net Income | 157.02M |
| EBITDA | 209.16M |
| EBIT | 189.25M |
| Earnings Per Share (EPS) | $3.97 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 673.61M |
| Total Debt | 209.39M |
| Net Cash | 464.22M |
| Net Cash Per Share | $11.78 |
| Equity (Book Value) | 1.58B |
| Book Value Per Share | 40.18 |
| Working Capital | 1.14B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 261.05M |
| Capital Expenditures | -60.75M |
| Depreciation & Amortization | 19.92M |
| Net Borrowing | -2.41M |
| Free Cash Flow | 200.29M |
| FCF Per Share | $5.08 |
Margins
| Measure | Value |
|---|
| Gross Margin | 67.98% |
| Operating Margin | 12.13% |
| Pretax Margin | 13.32% |
| Profit Margin | 10.06% |
| EBITDA Margin | 13.40% |
| EBIT Margin | 12.13% |
| FCF Margin | 12.84% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.31% |
| Shareholder Yield | n/a |
| Earnings Yield | 1.24% |
| FCF Yield | 1.59% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $362.54 |
| Price Target Difference | 13.67% |
| Analyst Consensus | Hold |
| Analyst Count | 17 |
| Revenue Growth Forecast (3Y) | 13.46% |
| EPS Growth Forecast (3Y) | 22.82% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 18.77 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |